Amylyx Targets Inflammation and Oxidative Stress with ALS Drug Combo
November 18, 2015
Cambridge, MA-based Amylyx Pharmaceuticals has received $600k in funding from the ALS Finding a Cure Foundation and the Cure Alzheimer’s Fund to advance preclinical development of its lead candidate,...
New IPOs Put Spotlight on Two Companies Combating Neurological Diseases
November 13, 2015
Two Boston-area biotech companies priced IPOs last week, raising millions of dollars for the development neurological disease therapies. WaVe Life Sciences produces “stereopure”...
Avalon and GSK Launch New Startup Focused on ALS
November 12, 2015
GlaxoSmithKline (GSK) and Avalon Ventures have partnered to fund a new ALS-focused start-up company called Iron Horse Therapeutics (not to be confused with the ALS...
New ALS Clinical Trial to Start for MediciNova’s Ibudilast
November 9, 2015
MediciNova, Inc., a biopharmaceutical company in La Jolla, California, has received FDA approval for a new Phase IIa clinical trial protocol for treating ALS patients with the small molecule, phosphodiesterase...
ALS Stratification Challenge Winners Developed Algorithms to Identify ALS Patient Subgroups
November 5, 2015
Prize4life, DREAM and Sage Bionetworks have announced the winning teams of the